Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 5.138B
March 31, 2026 5.205B
December 31, 2025 5.80B
September 30, 2025 4.505B
June 30, 2025 5.132B
March 31, 2025 5.976B
December 31, 2024 7.026B
September 30, 2024 6.867B
June 30, 2024 8.488B
March 31, 2024 8.54B
December 31, 2023 8.621B
September 30, 2023 7.573B
June 30, 2023 8.459B
March 31, 2023 8.923B
December 31, 2022 9.902B
September 30, 2022 8.348B
June 30, 2022 7.897B
March 31, 2022 10.12B
Date Value
December 31, 2021 10.73B
September 30, 2021 8.906B
June 30, 2021 7.99B
March 31, 2021 7.735B
December 31, 2020 4.609B
September 30, 2020 3.277B
June 30, 2020 2.718B
March 31, 2020 1.219B
December 31, 2019 1.104B
September 30, 2019 1.060B
June 30, 2019 1.070B
March 31, 2019 1.109B
December 31, 2018 1.522B
September 30, 2018 1.073B
June 30, 2018
March 31, 2018
December 31, 2017 756.98M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. 788.49M
BioNTech SE 16.89B
Kailera Therapeutics, Inc. 916.74M
Twist Bioscience Corp. 166.84M
Revolution Medicines, Inc. 3.938B